# FDA recall D-1540-2022

> **Pfizer Inc.** · Class I · drug recall initiated 2022-08-22.

## Product

PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of 10 vials (NDC Carton: 0409-4699-24), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

## Reason for recall

Presence of particulate matter

## Distribution

USA Nationwide

## Key facts

- **Recall number:** D-1540-2022
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-08-22
- **Report date:** 2022-09-21
- **Termination date:** 2025-06-30

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1540-2022

## Citation

> AI Analytics. FDA recall D-1540-2022. Retrieved 2026-07-19 from https://api.ai-analytics.org/recall/D-1540-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*